Skip to content Skip to footer

Alexandrea Day

Founder, CEO, Neurotech Innovator

Across two distinguished careers, Alexandrea has seamlessly bridged the realms of behavioral health and technological innovation, establishing herself as both a clinician deeply versed in behavioral science and a visionary in software development. Her journey began in the clinical domain, where her work in behavioral health provided her with profound insights into human psychology and the therapeutic potential of personalized interventions. This clinical foundation not only enriched her understanding of mental and emotional well-being but also set the stage for her subsequent ventures into technology, where she has applied her expertise to design and build software solutions that address complex human needs.

Transitioning into technology, Alexandrea emerged as a software visionary, conceiving and developing groundbreaking concepts that leverage the power of Brain-Computer Interface (BCI) technology and Artificial Intelligence (AI). Her innovative work includes an AI-driven chatbot integrated with BCI to offer highly personalized user experiences, touching on diverse applications such as mental health support through a “pocket therapist,” enhanced cybersecurity with neuro-identity technologies, and more. These inventions, guided by her deep clinical insights, illustrate her unique capacity to foresee and create technologies that not only advance digital interaction but also nurture the human spirit.

Her patented advancements in BCI, alongside her earlier conceptualizations like two-factor authentication, video preview technology, and a user-friendly video ad builder, underscore her role as a pioneer at the intersection of technology and human behavior. Alexandrea’s career is a testament to her exceptional ability to not just envision but also actualize software solutions that are both innovative and empathetically aligned with enhancing the quality of life, reflecting her dual legacy as a clinician and a software innovator.

Christopher Villa

Strategic Adviser

Christopher is a visionary entrepreneur and seasoned business leader with over 25 years of experience in catalyzing revenue growth and enhancing business performance from globally branded consumer goods to sports to emerging technology. Christopher brings a strong track record of data-driven sales, operations, strategy, and funding to MetaBrain Labs.

Having founded four companies with multiple exits, Christopher is currently the Principal of Nektur Advisory Partners, a firm that partners with emerging technology companies to help navigate the journey from bootstrapping to exiting.

Christopher earned his B.S In Environmental Design from the University of California, Davis. Married 24 years and with 2 adult children, Christopher is an active member of the Greater Seattle community.

Andrew M. Harrison

MD, PhD, Director of Healthcare Research

Andrew Harrison, MD, PhD is a physician and scientist, After completing undergraduate research training in physics and genetics he pursued MD-PhD training through the NIH-supported Medical Scientist Training Program at Mayo Clinic. The subject of his doctoral dissertation in Clinical Informatics with Critical Care was automated sepsis detection and alert. He was awarded a degree in Biomedical Sciences with a focus in Clinical and Translational Research. He continued Clinical Informatics research with Critical Care at Mayo Clinic as a postdoctoral Research Fellow. The focus of his work was use of machine learning (artificial intelligence) for hospital wide surveillance of critical illness. He then joined a medical device startup company during the pandemic focused on real time use of a flow cytometry device as a hematology analyzer coupled to advanced AI/ML analytics for blood-based disease detection and differentiation. He then pursued medical residency training in anesthesiology. Most recently he has done consulting focused on AI in healthcare such as generative AI and large language models (LLMs).

Andrew has published dozens of academic papers, book chapters, major grants, technical documents, regulatory documents, and more. He was employed by the Office for Diversity at Mayo Clinic as Managing Editor of their Diversity in Education Blog for 5 years. He has experience lobbying with multiple healthcare organizations in Washington, DC. He has served as National Policy Chair of the American Physician Scientists Association (ASPA) and as a student Editorial Board member of the Journal of the American Medical Informatics Association (JAMIA).

Robin Ann Yurk

MD, MPH, Senior Research & Ethics Council Adviser

Robin Ann Yurk, MD, MPH is a Physician | Senior Executive with 30+ years of Healthcare experience for Academic & Community Hospitals, Private Research Organization and Private companies for profit and nonprofit.  She has contributed to healthcare entrepreneur leadership as an entrepreneur CEO for MDyurk | DecisionShare, LLC with other C-suite team member roles, and as a Senior Medical Advisor for Wallcott Holdings, LLC a domestic and global healthcare infrastructure economic strategy.  She has 15 years of health system and front line physician experience from clinical practice with the HRSA BPHC Medical Center Foundations as a physician specialist. In addition, her medical training includes completion of a General Internal Medicine Fellowship from Johns Hopkins Medicine, a combined residency in Internal Medicine and Pediatrics at the University of North Carolina in Chapel Hill, a doctor of medicine from Creighton University School of Medicine and a Masters in Public Health from Johns Hopkins Bloomberg School of Public Health.

Issa Kildani

Director of Healthcare Commercialization

As the enterprising Founder and Principal Consultant of Ambrosia Ventures, exemplifies the pinnacle of innovation and strategic insight in the healthcare and biotechnology sectors. His career is a testament to an unwavering commitment to advancing medical science and commercializing groundbreaking technologies. At MetaBrain Labs, Issa’s visionary leadership since January 2024 has navigated the intricate process of bringing innovative products to market, harmonizing regulatory frameworks with aggressive business strategies to expedite product launches. Parallelly, his role at Ambrosia Ventures showcases his adeptness in steering healthcare entities through the industry’s complexities, providing tailored strategic advice that underscores his comprehensive understanding of biomedical science, regulatory compliance, and market dynamics. Issa’s academic foundation, with a Bachelor of Science in Psychology and a Master of Science in Biomedical Science from Wayne State University and Grand Valley State University, respectively, underpins his professional achievements. His journey from academia to a luminary in healthcare commercialization and consultancy demonstrates a relentless pursuit of transformative healthcare solutions, marked by a proactive approach to challenges and a collaborative spirit that fosters innovation and growth.

Dr. Roméo Farinacci

PhD, Ethics Council Adviser

Romeo specializes in Governance Risk and Compliance (GRC) with 20 years of experience in Data Privacy, Compliance Management, Cyber Security, and Audit. An executive level cybersecurity leader, speaker, and advisor delivering years of management and consultation on complex enterprise domains in public, private, defense, and government sectors. He drives design, evaluation, risk management, and reverse engineering of business risk and compliance to ensure regulatory alignment. 

Romeo has a doctorate in management from the University of Phoenix, an MBA, MIT, and multiple certifications including CISSP, CISM, CDPSE, CIPP/US, CMMC-RPA, and PMP.

Dr. Amanda Kavner

PhD, Computational Cognitive Science

Dr. Amanda Kavner, the Director of AI Implementation at MetaBrain Labs, is a trailblazer in the integration of artificial intelligence and neurocognitive science to predict human behavior. With a Ph.D. in Cognitive Science from SUNY University at Buffalo, her research is centered on leveraging machine learning and neurocognitive measurements to build predictive models that enhance mental health and educational outcomes. Her postdoctoral work in East Carolina University’s Neurocognitive Lab further solidified her expertise in cognitive process modeling and the application of AI in critical learning environments. Dr. Kavner’s groundbreaking work extends into the pioneering use of blockchain technology, particularly focusing on the potential of NFTs to safeguard neurodata and establish neurorights security. She is at the forefront of exploring how neurodata could revolutionize identity verification within finance and other sectors, proposing innovative methods for utilizing NFTs to ensure the ethical handling and protection of cognitive information. Her efforts signify a transformative step towards leveraging technology for more secure, inclusive, and advanced educational and societal systems.

Daniel Guest

President, MetaBrain Golf

Daniel’s passion for the game of golf has been growing his entire life, from an 8 year old hitting clubs he cut down with a neighbors hacksaw to competing at a high level. Originally from West Chester, PA,

Daniel honed his game to a single digit handicap while living in south Florida. In 2012 he founded Imagen Golf with his then teenage son to truly deliver the golf game that people always imagined. He is the host of the Imagen Golf Podcast, a frequent speaker at industry events and the author of the best-selling golf instruction book, Unleash the Golfer WITHIN.  Daniel’s teaching philosophy is based on the experience he has gained learning from some of the best and brightest minds in the golf world such as David Leadbetter, Butch Harmon, Mike Bender, Mo Norman, David Edel and Fred Shoemaker to name a few.

We Build Big Ideas

Newsletter Signup
Say Hello

MetaBrain Labs Inc © 2024. All Rights Reserved.